Company Filing History:
1 out of 1 
1 out of 240 
Years Active: 2019-2021
Title: Kim O'Connor: Innovator in Stem Cell Research
Introduction
Kim O'Connor is a prominent inventor based in New Orleans, LA (US). She has made significant contributions to the field of stem cell research, holding 2 patents that focus on enhancing the therapeutic use of stem cells. Her work aims to improve the identification and culture of multipotent mesenchymal stem cells, which are crucial for various medical applications.
Latest Patents
One of her latest patents is titled "Method for identification and culture of multipotent mesenchymal stem cells with high proliferation potential." This invention addresses the limitations in the therapeutic use of stem cells by providing a method to assess differentiation potential through the measurement of antigens CD 146 and NG2. The invention explores the correlation between these markers and the differentiation potential of stem cells, offering methods to amplify or enrich stem cell populations with desired characteristics.
Another significant patent is related to a "Cell-surface marker of early MSC aging." This invention identifies a specific cell-surface marker for aging mesenchymal stem cells (MSCs) and provides a method for screening MSCs with low proliferation potential. By removing CD264+ MSCs from the population, this method enhances the quality of stem cell cultures for research and therapeutic purposes.
Career Highlights
Throughout her career, Kim O'Connor has worked with notable organizations, including the Administrators of the Tulane Educational Fund Office of Technology Transfer and Intellectual Property Development. Her contributions to these institutions have helped advance the understanding and application of stem cell technology.
Collaborations
Due to space constraints, the details of her collaborations will not be included.
Conclusion
Kim O'Connor's innovative work in stem cell research has the potential to significantly impact therapeutic applications. Her patents reflect her dedication to advancing the field and improving the efficacy of stem cell therapies.